Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion type Assertion NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_head.
- NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion description "[In obese SHR-cp, compound 11 significantly decreased mean arterial pressure, glucose intolerance, insulin resistance, hypertriglyceridemia, and plasma renin activity with no effect on heart rate, body weight gain, or microalbuminuria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_provenance.
- NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion evidence source_evidence_literature NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_provenance.
- NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion SIO_000772 23586038 NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_provenance.
- NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion wasDerivedFrom befree-20140225 NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_provenance.
- NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_assertion wasGeneratedBy ECO_0000203 NP177569.RAR0ZHWS4e4wTEfsXMKsdCJiDu7VGbnIkVP7jCCFgIO_I130_provenance.